logo
CNBC Daily Open: Definite tariffs could be better for markets than on-and-off ones

CNBC Daily Open: Definite tariffs could be better for markets than on-and-off ones

CNBC5 days ago

A U.S. federal trade court striking down President Donald Trump's "reciprocal" tariffs on a broad swathe of countries seems, on the surface, a positive development all around. A lack of tariffs leads to cheaper goods, likely more consumer spending and higher corporate revenue, which tends to flow back to stock prices.
This ideal scenario, however, rests on the assumption that the court's decision is final and the Trump administration does not have other ways of reinstating its muscular trade policies.
Events on Thursday have already shown us that is not the case. An appeals court temporarily paused the tariff ruling to allow the Trump administration to respond to the case. "Even if we lose, we will do it another way," Trump trade advisor Peter Navarro told reporters at the White House Thursday afternoon.
This uncertainty could roil markets and trade negotiations with countries further. If tariffs could pop in and out of existence based on policy and judicial decisions, how do nations discuss trade deals, and how do investors allocate their capital efficiently? Indeed, the S&P 500 was up nearly 0.9% when trading began, but fell sharply after the Trump administration said it may ask the Supreme Court to halt the federal trade court's ruling.
"In general, markets don't like uncertainty, because it makes forecasting more difficult," said Larry Tentarelli, founder of the Blue Chip Daily Trend Report. "We expect the tariff news cycle to be an extended process, which can lead to higher short-term volatility."
In other words, if there was a definite universal tariff of 10% — while it's undeniably still a tax — the surety of it could be better for markets and economies globally in the long run.
Trump 'reciprocal' tariffs reinstated for nowA U.S. federal appeals court on Thursday granted the Trump administration's request to temporarily pause a lower-court ruling that struck down most of Trump's tariffs. Trump officials maintain that they have other options for imposing tariffs, even if they do not prevail in the case. Earlier in the day, the White House said it would seek "emergency relief" from the Supreme Court if the ruling was not paused.
U.S. market gains capped by tariff confusionU.S. stocks rose Thursday. They were buoyed by Nvidia — which climbed 3.3% on its positive earnings — but were held back from bigger gains by uncertainty around tariffs. The S&P 500 added 0.4%, the Dow Jones Industrial Average gained 0.28% and the Nasdaq Composite climbed 0.39%. Europe's Stoxx 600 index slipped 0.19% and Germany's Dax lost 0.44% — but the latter is still up more than 20% year to date.
Powell stressed rate decisions cannot be politicalFederal Reserve Chair Jerome Powell met Trump Thursday, according to a release by the U.S. central bank. "Chair Powell did not discuss his expectations for monetary policy," the statement said. However, Powell did "stress that the path of policy will depend entirely on incoming economic information and what that means for the outlook" — essentially, that interest rates cannot be swayed by politics.
SEC dropped its lawsuit against BinanceThe SEC has formally dropped its lawsuit against Binance and founder Changpeng Zhao, which was first brought in June 2023. The case had accused the crypto exchange of illegally serving U.S. users, inflating trading volumes and commingling customer funds. The dismissal marks a symbolic end to the agency's crypto crackdown and comes as the Trump administration attempts to prove it's an ally to the industry.
[PRO] European sectors to play: JPMorganEuropean equities have fared better than those in the U.S. so far this year. JPMorgan analysts think the trend could continue, with non-U.S. markets trading "increasingly more favorably" against their American counterparts for the next 12 to 18 months. Here are the bank's preferred sectors for this period.
Musk-Altman AI rivalry is complicating Trump's dealmaking in Middle East
Elon Musk tried to derail a major artificial intelligence infrastructure deal in the Middle East after learning that his startup, xAI, would be excluded from the initiative, CNBC has confirmed.
Earlier this month, OpenAI, Oracle, Nvidia, Cisco and Emirati firm G42 announced plans to build a sweeping Stargate AI campus in the United Arab Emirates. Musk was frustrated that OpenAI, led by personal rival Sam Altman, was tapped for the deal, and he intervened in an effort to get xAI involved, said a person familiar with the matter who asked not to be named in order to speak freely.
Musk argued that Trump would not approve the deal, the person said. The announcement was delayed by several days as stakeholders, including the White House, dealt with blowback from Musk, who has been engaged in a public and legal spat with Altman and OpenAI.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

JPMorgan's Jamie Dimon is getting louder about his US debt worries
JPMorgan's Jamie Dimon is getting louder about his US debt worries

Yahoo

time3 minutes ago

  • Yahoo

JPMorgan's Jamie Dimon is getting louder about his US debt worries

JPMorgan Chase (JPM) CEO Jamie Dimon is increasingly concerned that the US government's surging debt is going to cause problems for the bond market, prompting some pushback from Treasury Secretary Scott Bessent. Last Friday, the boss of the biggest US bank predicted a "crack" in that market while speaking at the Reagan National Economic Forum in Simi Valley, Calif. "It is going to happen. And I tell this to my regulators, some of you who are in this room, I'm telling you it's going to happen, and you're going to panic." This past weekend, Bessent dismissed that prediction, saying Dimon has made it before. "I've known Jamie a long time and for his entire career he's made predictions like this. Fortunately, none of them have come true. That's why he's a banker, a great banker. He tries to look around the corner," Bessent said in an interview on CBS' "Face the Nation." Dimon emerged in 2025 as an influential voice when it comes to the policies of the new Trump administration — and as someone who apparently has President Trump's ear. The president even acknowledged listening to Dimon just hours before he announced a 90-day pause of his "Liberation Day" tariffs on April 9. Dimon repeated his warnings about the bond market in an interview with Fox Business Network's Maria Bartiromo that aired Monday, saying the surging US national debt may create a "tough time" for that market as spreads widen. "If people decide that the US dollar isn't the place to be, you could see credit spreads gap out; that would be quite a problem," Dimon said. "It hurts the people raising money. That includes small businesses, that includes loans to small businesses, includes high-yield debt, includes leveraged lending, includes real estate loans. That's why you should worry about volatility in the bond market." Long-term Treasury yields have been climbing in recent weeks, driven by growing concerns over the trajectory of US debt as President Trump's proposed tax legislation advances to the Senate after clearing the House. Read more: What is the 10-year Treasury note, and how does it affect your finances? New concerns emerged last week after a Manhattan-based trade court struck down a wide swath of Trump's tariffs, citing legal issues with how they were implemented. Although a federal appeals court paused that decision on Thursday, temporarily allowing the tariffs to remain in place, the legal back-and-forth has added to market uncertainty. Treasury yields initially spiked on Monday, with the 10-year (^TNX) climbing to 4.46% while the 30-year (^TYX) reached 4.99% by the end of the day. They briefly retreated on Tuesday, only to return to Monday levels, a threshold breached only a handful of times since 2007. Bessent told CBS this past weekend that the administration's work on getting down the deficit is underway. "The deficit this year is going to be lower than the deficit last year, and in two years it will be lower again," he said. "We are going to bring the deficit down slowly. We didn't get here in one year, and this has been a long process." The administration intends to "leave the country in great shape in 2028," he added. One area that would cushion a bond market tantrum that the Trump administration has clearly telegraphed is giving JPMorgan and other big banks a larger role as US Treasury holders, and possibly dealers. Bessent has repeatedly said he wants to adjust a bank capital requirement known as the supplemental leverage ratio (SLR) to make it easier for lenders in order to inject more liquidity into the market for US government debt. Dimon agrees that amending the SLR would help the market during times of stress, though he noted that he also wants to see reforms across lots of capital requirements. "The reason to change some of these things is so banks — the big market makers could intermediate more in the markets," Dimon told analysts in April. "If they do, spreads will come in, there'll be more active traders," Dimon said. "If they don't, the Fed will have to intermediate, which I think is just a bad policy idea that every time there's a kerfuffle in the markets, the Fed has to come in and intermediate." To prevent a bond market crack, Dimon said in the Fox News interview that aired Monday, "the real focus should be [economic] growth." He also named several places for improvement from regulatory, permitting, and education reforms to broader government efficiency efforts meant to stamp out waste and fraud in Medicare and Medicaid. Dimon gave Fox an update about his plans to leave the bank eventually, saying that his retirement is still "several years away" but that "it's up to God and the board," the 69-year-old CEO said. "I love what I do." On Tuesday, the bank announced in a memo that it was giving more responsibility to one of Dimon's potential successors, consumer bank boss Marianne Lake. Lake will also oversee strategic growth and the overseas consumer bank following Sanoke Viswanathan's departure to become CEO of data provider FactSet. David Hollerith is a senior reporter for Yahoo Finance covering banking, crypto, and other areas in finance. Click here for in-depth analysis of the latest stock market news and events moving stock prices Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

AbbVie (NYSE:ABBV) Showcases Promising Phase 1 ADC Results For Advanced Cancers
AbbVie (NYSE:ABBV) Showcases Promising Phase 1 ADC Results For Advanced Cancers

Yahoo

time5 minutes ago

  • Yahoo

AbbVie (NYSE:ABBV) Showcases Promising Phase 1 ADC Results For Advanced Cancers

AbbVie recently unveiled promising data on its investigational therapies, including the novel c-Met-targeting ADC, Temab-A, and the SEZ6-directed ADC, ABBV-706, indicating progress in their clinical pipelines. Despite these announcements, AbbVie's stock price remained flat, aligned with overall market stability. The market awaited significant financial updates, such as Nvidia's anticipated earnings report, contributing to a general holding pattern in stock movements. While AbbVie's steady price echoes broader market trends, the therapeutic advancements underscore the company's ongoing commitment to developing innovative treatments. Every company has risks, and we've spotted 5 weaknesses for AbbVie you should know about. We've found 17 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. The recent announcements regarding AbbVie's investigational therapies, including Temab-A and ABBV-706, stand to reinforce the narrative focused on pipeline growth and market expansion. These advancements could catalyze future revenues, particularly within the obesity and oncology sectors. This aligns with AbbVie's aim to leverage clinical progress to enhance financial outcomes, though immediate impacts on revenue and earnings forecasts might require more time to materialize. Given that the share price remained flat despite the positive pipeline developments, it appears the market is waiting for further validation of potential revenue contributions. Over the past five years, AbbVie's total shareholder return, combining share price appreciation and dividends, reached 150.37%, reflecting a robust long-term performance. In comparison, the company outperformed the US Biotechs industry, which saw a decline of 10.4% over the last year, highlighting AbbVie's relative strength in a challenging market environment. Currently, AbbVie's share price trades at approximately US$187.15, positioning it at a discount relative to the consensus price target of US$210.68. This indicates an 11.2% potential upside according to the analysts' expectations. The stability in the stock price, despite the recent news on clinical advancements, suggests investors might be holding out for more substantial financial data that aligns with the projected growth in revenues, where analysts foresee a progression to around US$70 billion by 2028. Unlock comprehensive insights into our analysis of AbbVie stock in this financial health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:ABBV. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Elon Musk Calls Trump Megabill a ‘Disgusting Abomination'
Elon Musk Calls Trump Megabill a ‘Disgusting Abomination'

Wall Street Journal

time10 minutes ago

  • Wall Street Journal

Elon Musk Calls Trump Megabill a ‘Disgusting Abomination'

WASHINGTON—Former White House cost-cutting czar Elon Musk called President Trump's 'big, beautiful' tax and spending package a 'disgusting abomination,' stepping up his criticism just as the Senate is trying to quickly pass the measure and get it signed into law by July 4. 'Shame on those who voted for it: you know you did wrong. You know it,' said Musk, in comments on his X social-media platform. Musk, who left the administration last week, called the package a 'massive, outrageous, pork-filled Congressional spending bill.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store